bellus health inc
(BLU:Toronto Stock Exchange)
Denis Garceau Ph.D.
Senior Vice President of Drug Development,BELLUS Health Inc.
|Age||Total Calculated Compensation||This person is connected to 21 board members in 1 different organizations across 3 different industries.|
See Board Relationships
As of Fiscal Year 2014
Dr. Denis Garceau, Ph.D. has been a Senior Vice President of Drug Development of BELLUS Health Inc. since January 20, 2005. Dr. Garceau serves as the Chief Science Officer of OVOS Natural Health Inc. and directs OVOS Natural Health's product development program from toxicology to clinical evaluation through regulatory approval of new products. He served as Vice-President of Drug Development at BELLUS Health Inc. until January 20, 2005. He served as a Clinical Scientist ...
275 Armand-Frappier BoulevardPhone: 450-680-4500
Laval, Quebec H7V 4A7
Board Members Memberships*
Universite De Montreal, L'
|Ian C. Read||Chairman, Chief Executive Officer and Chairman of Executive Committee|
|John C. Lechleiter Ph.D.||Chairman, Chief Executive Officer and President|
Eli Lilly and Company
|Joseph Jimenez Jr., MBA||Chief Executive Officer|
|Elliot Goldstein M.D.||Chief Executive Officer, President, Director, Member of Corporate Governance and Nominating Committee and Member of Compensation Committee|
ProMIS Neurosciences Inc.
|--||Compensation as of Fiscal Year 2014.|